3rd Quarter - Report

BROWN RUDNICK LLP for APOTEX CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 3610, Food and Drug Importation Safety Act Status of ANDA #76-369 regarding calcitonin salmon nasal spray

Foreign entity interest: Apotex Holdings Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.

LobbyistCovered position, as disclosed
HENRY W MENN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3610 (110th)

Medicare/Medicaid MMM

H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008

Foreign entity interest: Apotex Holdings Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.

LobbyistCovered position, as disclosed
HENRY W MENN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6331 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.